PLAY PODCASTS
Expert Highlights From the 2025 World Conference on Lung Cancer
Episode 224

Expert Highlights From the 2025 World Conference on Lung Cancer

Listen to Dr John Heymach and Dr Solange Peters discuss key data presented at the 2025 World Conference on Lung Cancer regarding frontline maintenance for extensive-stage small-cell lung cancer and targeted treatments for non-small-cell lung cancer and how they may change the treatment paradigm.

Decera Clinical Education Oncology Podcast · John Heymach MD PhD, Solange Peters MD PhD

December 24, 202524m 30s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Dr John Heymach and Dr Solange Peters discuss key data presented at the IASLC World Conference on Lung Cancer including first-line maintenance in ES-SCLC (IMforte and DeLLphi-303 trials) and targeted treatment for NSCLC (FLAURA2, Beamion LUNG-1, and ARROS-1 trials).

Presenters:

John Heymach, MD, PhD
Chair and Professor
Department of Thoracic/Head and Neck Medical Oncology
Ruth Legett Jones Distinguished Chair
MD Anderson Cancer Center
Houston, Texas

Solange Peters, MD, PhD 
Professor and Director of Medical Oncology
Department of Oncology
University Hospital of Lausanne
Lausanne, Switzerland

Content based on an online CME program supported by independent educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Jazz Pharmaceuticals, Inc.

Link to full program: 
https://bit.ly/3L1eksI

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

lurbinectedinbrain metastasisintracranial responsewclc 2025extensive-stage small-cell lung cancersmall-cell lung cancerimforteosimertinibdellphi-303ros1world conference on lung cancernsclcarros-1zidesamtinibmaintenanceflaura2tarlatamabbeamion lung-1her2egfrmcns activitysclcher2-activating mutationssafetyplatinum etoposidetkiexon 20 insertioniaslcconference coveragetargeted therapydurvalumabnon-small-cell lung canceregfr mutatedwclcatezolizumabcns diseasebrain metastasesegfres-sclczongertinibher2mher2 mutant